Technical Analysis for TYP - Tryptamine Therapeutics Limited
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| A | 0.033 | 3.13% | 0.001 |
TYP closed up 3.13 percent on Friday, November 1, 2024, on 2.24 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
Earnings due: Nov 22
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Stochastic Sell Signal | Bearish | 0.00% | |
| Calm After Storm | Range Contraction | 0.00% | |
| Parabolic Rise | Strength | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Above Upper BB | Strength | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Jack-in-the-Box Bullish | Bullish Swing Setup | 3.13% | |
| Parabolic Rise | Strength | 3.13% | |
| Upper Bollinger Band Walk | Strength | 3.13% |
| Alert | Time |
|---|---|
| 1.5x Volume Pace | 1 day ago |
| Up 2% | 2 days ago |
| Up 1% | 2 days ago |
| Up 3% | 2 days ago |
| Gap Up Closed | 3 days ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
Tryp Therapeutics Inc., a clinical-stage pharmaceutical development company, focuses on developing psilocybin-related molecules in Canada and the United States. Its lead program candidate TRP-8803, a proprietary formulation of IV-infused psilocin that completed Phase 2a clinical trial for the treatment of binge eating disorder, fibromyalgia, abdominal pain, and visceral tenderness. The company's program candidate TRP-8802, a synthetic and oral psilocybin for the treatment of binge eating, chronic pain, and other indications. The company was formerly known as Artos Pharma Corp. and changed its name to Tryp Therapeutics Inc. in June 2020. Tryp Therapeutics Inc. was incorporated in 2019 and is based in Kelowna, Canada.
Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Development
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Development
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 0.036 |
| 52 Week Low | 0.017 |
| Average Volume | 2,536,753 |
| 200-Day Moving Average | 0.000 |
| 50-Day Moving Average | 0.020 |
| 20-Day Moving Average | 0.022 |
| 10-Day Moving Average | 0.024 |
| Average True Range | 0.002 |
| RSI (14) | 69.23 |
| ADX | 23.22 |
| +DI | 52.516 |
| -DI | 9.120 |
| Chandelier Exit (Long, 3 ATRs) | 0.029 |
| Chandelier Exit (Short, 3 ATRs) | 0.024 |
| Upper Bollinger Bands | 0.031 |
| Lower Bollinger Band | 0.012 |
| Percent B (%b) | 1.09 |
| BandWidth | 90.233 |
| MACD Line | 0.003 |
| MACD Signal Line | 0.001 |
| MACD Histogram | 0.0016 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.036 | ||||
| Resistance 3 (R3) | 0.036 | 0.035 | 0.036 | ||
| Resistance 2 (R2) | 0.035 | 0.034 | 0.035 | 0.035 | |
| Resistance 1 (R1) | 0.034 | 0.034 | 0.035 | 0.034 | 0.035 |
| Pivot Point | 0.033 | 0.033 | 0.033 | 0.033 | 0.033 |
| Support 1 (S1) | 0.032 | 0.032 | 0.033 | 0.032 | 0.031 |
| Support 2 (S2) | 0.031 | 0.032 | 0.031 | 0.031 | |
| Support 3 (S3) | 0.030 | 0.031 | 0.031 | ||
| Support 4 (S4) | 0.030 |
